Source link : https://www.newshealth.biz/health-news/new-molecules-reflect-advances-in-atopic-dermatitis/
Cyclosporine is still the gold standard for treating atopic dermatitis in adults requiring systemic treatment. It is, however, supported by a growing number of molecules. First, we have dupilumab and tralokinumab, which target the alpha subunit of the interleukin (IL)-4 receptor common to IL-13, and IL-13, respectively. Then, we have the Janus kinase (JAK) inhibitors […]
Author : News Health
Publish date : 2024-01-18 08:57:25
Copyright for syndicated content belongs to the linked Source.